JDP what are your thoughts on price action between now and the end of the financial year?
My 2 cents worth, a build up to $2 before Tox and Safety studies results wouldn't be out of the question. If RC220 is given the go ahead for human use that would be a driver to get SP back over $3 (first CP announce price zone). After that, if the clinical trial design can give an indication of TAM, RAC might actually start to get a SP that reflects the true value/risk opportunity that is available.
RAC - Charts & Price Action, page-20330
-
- There are more pages in this discussion • 1,224 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.090(5.59%) |
Mkt cap ! $289.5M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.76 | $1.59 | $142.7K | 84.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17175 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.77 | 6060 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |